11 SET 2023 · Listen in as the CEO of TD2, Dr. Stephen Gately, sits down with Dr. Ed Weinstein, co-founder and CEO of Panome Bio, to discuss their important research on metabolomics and proteomics. Gain insights into new screening technology for important metabolic and proteomic changes that occur in response to new drugs in development for cancer patients.

30 SET 2022 · In this inaugural episode, Dr. Gately sits down with Dr. Emanuel “Chip” Petricoin, professor at George Mason University in the School of Systems Biology, Co-Director of the Center for Applied Proteomics and Molecular Medicine and founder and chairman of the scientific advisory board at Theralink Technologies. The two delve into a deep discussion on the development of Reverse Phase Protein Array technology, the importance of next-generation sequencing in partnership with proteomic analyses, and much more.